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Keratoconus (KC; Mendelian Inheritance in Man [MIM]
14830)  is  a  rare  disease  characterized  by  thinning  of  the
corneal  stroma,  resulting  in  reduced  vision,  irregular
astigmatism and corneal scarring. The age of onset is mostly
at puberty with the estimated prevalence of KC is 1–4 in 2000
in general population. Exact cause of KC is still unclear,
although  pathogenesis  may  involve  genetic  [1,2],
environmental and behavioral factors [3,4]. KC is one of the
most common cause for corneal transplantation. Inheritance
of KC does not usually follow a simple Mendelian inheritance
in majority of cases and appears to be sporadic [5], but positive
family history is reported in 6% to 10% of patients [6]. Both
recessive  and  dominant  pattern  of  inheritance  have  been
reported  with  predominance  of  autosomal  dominant
inheritance  and  disease  shows  incomplete  penetrance  and
variable  expressivity  [7,8].  Since,  cornea  is  an  avascular
structure and first target of ultraviolet radiation entering the
eyes, it is potentially vulnerable to oxidative stress [9]. Studies
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report the role of oxidative damage in KC and other corneal
diseases [10,11].
In a previous study from our laboratory we have reported
association of mtDNA variations with congenital glaucoma
[12]. We have shown the presence of mtDNA complex I
sequence variations which were associated with elevated ROS
production in congenital glaucoma. In this pilot study we
reported the results of mitochondrial complex I gene analysis
in  20  keratoconus  patients  negative  for  Visual  System
Homeobox 1 (VSX1) mutations [13].
METHODS
Ethics  statement:  All  patients  provided  informed  consent
before participation in this study. The study was approved by
Institutional Review Board (IRB00006862; All India Institute
of Medical Sciences, New Delhi, India).
Clinical examination and selection of cases: A total of twenty
keratoconus patients (Table 1) presented (during April 2009
to April 2010) at the Dr. R. P. Centre for Ophthalmic Sciences
(AIIMS,  New  Delhi,  India)  were  enrolled  in  this  study.
Clinical  evaluation  involved  Ultrasonic  Pachymetry,
videokeratography  (VKG),  Orbscan,  visual  testing,
fundoscopy,  slitlamp-biomicroscopy,  and  retinoscopy.  Of
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Purpose: Keratoconus is characterized by the thinning of corneal stroma, resulting in reduced vision. The exact etiology
of keratoconus (KC) is still unknown. The involvement of oxidative stress (OS) in this disease has been reported. However,
the exact mechanism of OS in keratoconus is still unknown. Thus we planned this study to screen mitochondrial complex
I genes for sequence changes in keratoconus patients and controls, as mitochondrial complex I is the chief source of
reactive oxygen species (ROS) production.
Methods: A total of 20 keratoconus cases and 20 healthy controls without any ocular disorder were enrolled in this study.
Mitochondrial complex I genes (ND1, 2, 3, 4, 4L, 5, and 6) were amplified in all patients and controls using 12 pairs of
primers  by  PCR.  After  sequencing,  DNA  sequences  were  analyzed  against  the  mitochondrial  reference  sequence
NC_012920. Haplogroup frequency based Principle Component Analysis (PCA) was constructed to determine whether
the gene pool of keratoconus patients is closer to major populations in India.
Results: DNA sequencing revealed a total 84 nucleotide variations in patients and 29 in controls. Of 84 nucleotide changes,
18 variations were non-synonymous and two novel frame-shift mutations were detected in cases. Non-synonymous
mtDNA sequence variations may account for increased ROS and decreased ATP production. This ultimately leads to OS;
which is a known cause for variety of corneal abnormalities. Haplotype analysis showed that most of the patients were
clustered under the haplogroups: T, C4a2a, R2’TJ, M21’Q1a, M12’G2a2a, M8’CZ and M7a2a, which are present as
negligible frequency in normal Indian population, whereas only few patients were found to be a part of the other
haplogroups like U7 (Indo-European), R2 and R31, whose origin is contentious.
Conclusions: Mt complex I sequence variations are the main cause of elevated ROS production which leads oxidative
stress. This oxidative stress then starts a cascade of events which ultimately can lead to keratoconus. Prompt antioxidant
therapy should be initiated in keratoconus patients to minimize ROS related damage.
2 2these patients, 14 were males and 6 were females. The mean
age of presentation was 17.2 years. Diagnosis of keratoconus
involved the presence of characteristic topographic features,
such  as  inferior  or  central  corneal  steepening,  or  an
asymmetric bowtie pattern with skewing of the radial axes,
and  the  presence  of  one  or  more  of  the  following
characteristic, clinical features in one or both eyes: conical
corneal deformation, munsen sign, corneal stromal thinning,
a Fleischer ring or Vogt striae. Family history up to three
generations was collected and pedigrees were drawn. All 20
cases  were  sporadic  without  any  family  history.  All
keratoconus cases secondary to causes like trauma, surgery,
Ehlers  Danlos  syndrome,  osteogenesis  imperfecta,  and
pellucid marginal degeneration were excluded from the study.
Twenty ethnically matched normal individuals without any
ocular disorder were enrolled as controls. Health information
was obtained from controls through the questionnaire; all
underwent ophthalmological examination. Five milliliters of
blood  was  collected  by  venipuncture  in  EDTA  (EDTA)
vaccutainers  (Greiner  Bio-One  GmbH,  Frickenhausen,
Germany)  from  both  patients  and  controls.  DNA  was
extracted from whole blood samples by the inorganic method.
For the population study, controls were taken from published
data defining the lineage of the Indian population [14,15].
Polymerase chain reaction (PCR) amplification and sequence
analysis  of  the  mitochondrial  DNA  coding  region:  The
mitochondrial  complex  1  (ND1,  ND2,  ND3,  ND4,  ND4L,
ND5, and ND6 [ND stands for NADH dehydrogenase]) was
amplified in all patients and controls using 12 pairs of primers
using  cycling  conditions  as  described  by  Kumar  and
associates  [16]  and  presented  in  Table  2.  Briefly,  PCR
amplifications for all primer sets were performed in a 40-μl
volume containing 1.0 μl of 20 μM stock solution for each
primer (Eurofins Genomics India pvt Ltd, Bangalore, India),
100 ng of genomic DNA, 1 unit of Taq polymerase (Banglore
Genei,  Bengaluru,  Karnataka,  India),  0.1  mM  of  each
deoxynucleotide triphosphate (dNTP), and 4 μl of 10× PCR
buffer  (with  15  mM  MgCl2)  by  means  of  30  cycles  of
amplification, each consisting of 30 s denaturation at 94 °C,
30 s annealing at 55 °C, and 1 min extension at 72 °C. Finally,
an extension for 5 min at 72 °C was performed. Amplified
PCR products were purified using a gel/PCR DNA fragments
extraction kit (catalog number DF100; Geneaid Biotech Ltd.,
All sequence variants from both KC patients and controls were
compared to the Human Mitochondrial reference sequence
NC_012920  provided  by  the  National  Center  for
Biotechnology  Information  (NCBI)  using  ClustalW2
(multiple sequence alignment program for DNA; European
Molecular  Biology  Laboratory  (EMBL)-European
Bioinformatics Institute (EBI).
Computational  assessment  of  missense  mutations:  For
prediction  of  pathogenic  characteristics  of  all  non-
synonymous mtDNA changes two homology based programs
PolyPhen-2 (Polymorphism Phenotyping) and SIFT (Sorting
PolyPhen  structurally  analyzes  an  amino  acid
polymorphism and predicts whether that amino acid change
is  likely  to  be  deleterious  to  protein  function  [17-19].
Polyphen-2 is more advanced version of the earlier version
PolyPhen  [20].  The  prediction  is  based  on  the  position-
specific  independent  counts  (PSIC)  score  derived  from
multiple  sequence  alignments  of  observations  in  case  of
functional domain of protein and predicted hydrophobic and
transmembrane (PHAT) matrix element difference in case of
transmembrane region of protein. PolyPhen scores of above
0.85  indicate  the  polymorphism  is  probably  damaging  to
protein function. Scores of above 0.15 are possibly damaging,
and scores of less than 0.15 are classified as benign.
SIFT  is  a  sequence  homology-based  tool  that  sorts
intolerant from tolerant amino acid substitutions and predicts
whether an amino acid substitution in a protein will have a
phenotypic effect [21-23]. SIFT is based on the premise that
protein evolution is correlated with protein function. Positions
important for function should be conserved in an alignment
of the protein family, whereas unimportant positions should
appear diverse in an alignment. Positions with normalized
probabilities less than 0.05 are predicted to be deleterious and,
those greater than or equal to 0.05 are predicted to be tolerated.
Haplogroup and phylogenetic analysis: To check the fidelity
of  our  conclusion,  the  evolutionary  information  and  the
significance of mutations should be known. For haplogroups
(Hg) analysis we have carefully chosen two hundred healthy
individual samples from same area for comparison analysis
and these were also treated as controls. For all control samples,
sequences  of  the  control  region  were  determined  from
position 16024 to 00300, using the ABI Prism Dye Terminator
cycle-sequencing  protocols  developed  by  Applied
Biosystems (Perkin-Elmer, Foster City, CA), to provide an
initial presumed Hg assignment and cases were haplogrouped
by complete coding region sequences. The C-track length
variation at positions 16182 and 16183 in HVS-I and the
indels at positions 00309 and 00315 in HVS-II were excluded
from further analyses. Hg assignment was then confirmed,
based  on  control  and  coding  region  Hg  defining
polymorphisms determined by means of direct sequencing.
The NETWORK 4.5.1.6 program was run for placing all
the  mutations  of  control  samples  in  their  respective
phylogenetic tree using the protocol as described at the Fluxus
Engineering Website. The matrilineal lineages of the case
were  drawn  manually  in  the  reduced  median  network  of
control samples, to create the topology map we have applied
the reduced median algorithm (r=1), followed by the median-
joining algorithm (epsilon=2).
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Sijhih City, Taiwan). Purified PCR products of both primers
(forward and reverse) were sent for sequencing to MCLAB
(Molecular Cloning Laboratories, South San Francisco, CA).
Intolerant From Tolerant) were used.T
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1516Principal  component  analysis:  To  minimize  errors  both
strands were double-sequenced. Principal component analysis
(PCA) of mtDNA was performed. For this experiment we
compiled our data of mitochondrial haplogroups. Controls
samples  of  five  different  populations  were  taken  from
published  data  defining  Indian  lineage  for  comparative
analysis representing each sector of India i.e., Northern India,
North-Western  India,  Western  India,  Eastern  India,  and
Southern India.
The MVSP software package (Kovach WL, Services KC.
MVSP - A multi-variate statistical package for Windows ver
3.13m. 2004) was used to identify the principal components
(PCs)  of  mitochondrial  variations  that  lead  to  form  a
haplogroup  for  every  individual.  To  express  the  relative
importance of top two eigenvectors in the resulting PCA plot,
two axes were scaled by a factor equal to the square root of
the corresponding eigen value. This experiment was repeated
to confirm the outcomes.
RESULTS
Sequence variation in Complex I genes: DNA sequencing of
Complex I genes revealed a total 84 nucleotide variation in
patients (Table 3) and 29 variations in controls (Table 4). Of
the 84 nucleotide variations in patients, 18 (21.42%) were non
synonymous (Table 5), 52 (61.90%) were synonymous, 9
(10.71%) variations were in RNA genes and 3 (3.57%) were
Of  84  variations,  2  variations  were  frame-shift
(11273G>A, 5300T>T). In one patient (KC 16) a single base
deletion of guanine was observed at mtDNA position 11273.
This caused a frame shift mutation after codon 172 (Gly>Ala)
and introduced a stop codon at position 174 which resulted in
a  173  amino  acids  truncated  protein.This  variation  was
homoplasmic (Figure 1).
In patient KC 2, we found a 2 base pair (CA) deletion at
genomic position 5300 and 5301. This frame shift mutation
altered  the  amino  acid  reading  frame  in  ND2  protein  at
position 277. This CA deletion produced a truncated protein
of 287 amino acids (Figure 2).
In silico analysis:  SIFT analysis revealed two pathogenic
changes  (p.L71I  and  p.T9A)  and  PolyPhen  revealed  two
pathogenic changes (p.N30L and p.I172V). The polyphen
score of p.T9A was not available (no result for this mutation
was available through PolyPhen; Table 5).
TABLE 2. PRIMER USED FOR AMPLIFICATION OF COMPLEX-I GENE OF MITOCHONDRIA.
Primer
name
Primer sequence Product size Melting temperature (°C)
1 F-3’GGACTAACCCCTATACCTTCTGC5’      
   R-3’GGCAGGTCAATTTCACTGGT5’ 859 55
2 F-3’AAATCTTACCCCGCCTGTTT5’      
   R-3’AGGAATGCCATTGCGATTAG5’ 885 55
3 F-3’TACTTCACAAAGCGCCTTCC5’      
   R-3’ATGAAGAATAGGGCGAAGGG5’ 831 55
4 F-3’TGGCTCCTTTAACCTCTCCA5’      
   R-3’AAGGATTATGGATGCGGTTG5’ 903 55
5 F-3’ACTAATTAATCCCCTGGCCC5’      
   R-3’CCTGGGGTGGGTTTTGTATG5’ 978 55
6 F-3’TCTCCATCTATTGATGAGGGTCT5’      
   R-3’AATTAGGCTGTGGGTGGTTG5’ 892 55
7 F-3’GCCATACTAGTCTTTGCCGC5’      
   R-3’TTGAGAATGAGTGTGAGGCG5’ 859 55
8 F-3’TCACTCTCACTGCCCAAGAA5’      
   R-3’GGAGAATGGGGGATAGGTGT5’ 801 55
9 F-3’TATCACTCTCCTACTTACAG5’      
   R-3’AGAAGGATATAATTCCTACG5’ 865 55
10 F-3’AAACAACCCAGCTCTCCCTAA5’      
   R-3’TCGATGATGTGGTCTTTGGA5’ 976 55
11 F-3’ACATCTGTACCCACGCCTTC5’      
   R-3’AGAGGGGTCAGGGTTGATTC5’ 969 55
12 F-3’GCATAATTAAACTTTACTTC5’      
   R-3’AGAATATTGAGGCGCCATTG5’ 937 55
Molecular Vision 2011; 17:1514-1525 <http://www.molvis.org/molvis/v17/a170> © 2011 Molecular Vision
1517
in  non-coding  region.  Of  84  nucleotide  variations  in  KC
patients; five variations (3918G>A, 5348C>T, 12007G>A,
12372G>A and 12561G>A) were also present in controls. Out
of 29 nucleotide variations found in controls 5 were non-
synonymous. Maximum nucleotide variations were in ND5
(n=28) followed by ND4 (n=15); ND2 (n=13); ND3 (n=7);
ND1 (n=3); ND4L (n=3), tRNAs (n=9), rRNAs (n=2) and 3
in non-coding regions.T
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1519Principle component analysis: The tight cluster in Principal
component Analysis (PCA) plot comprises the north-western,
western, and north Indian population whereas the southern
Indian and eastern Indian population is caught in a loose
cluster (Figure 3). The controls were taken from published
data  defining  Indian  lineage  for  PCA  and  Haplogroup
Network. We have treated the patients as a sub group of
individuals having genetic structure different from normal
Indians  e.g.,  population.  The  inferences  from  PCA  plot
strongly  supports  our  motive  behind  the  planning  of
experiment, interestingly the patient population has not shown
any relevant genetic affinity with other macropopulations of
India.
TABLE 4. COMPLEX 1 VARIATIONS OBSERVED IN CONTROLS.
Sample
number
Genomic
position
Base
change
Locus Amino acid
position
Codon change Amino acid
change
Change in
protein
1 3591 G>A ND1 95 CTG>CTA Thr>Thr p.T95T
2 3915 G>A ND1 203 GGG>GGA Gly>Gly p.G203G
3 3918 G>A ND1 204 GAG>GAA Glu>Glu p.E204E
4 3933 A>G ND1 209 TCA>TCG Ser>Ser p.S209S
5 3970 C>T ND1 222 CTA>TTA Leu>Leu p.L222L
6 3996 C>T ND1 230 AAC>AAT Asn>Asn p.N230N
7 4093 A>G ND1 263 ACC>GCC Thr>Ala p.T263A
8 4029 C>A ND1 241 ATC>ATA Ile>Ile p.I241I
9 4793 A>G ND2 108 ATA>ATG Met>Met p.M108M
10 4852 T>A ND2 128 CTG>CAG Leu>Gln p.L128Q
11 5186 A>T ND2 239 TGA>TGT Trp>Cys p.W239C
12 5348 C>T ND2 293 TAC>TAT Tyr>Tyr p.Y293Y
13 10310 G>A ND3 84 CTG>CTA Thr>Thr p.T84T
14 11467 A>G ND4 236 TTA>TTG Leu>Leu p.L236L
15 11914 G>A ND4 385 ACG>ACA Thr>Thr p.T385T
16 12007 G>A ND4 416 TGG>TGA Trp>Trp p.W416W
17 12073 C>T ND4 438 TTC>TTT Phe>Phe p.F438F
18 12107 C>T ND4 449 CTC>CTT Thr>Thr p.T449T
19 12133 C>T ND4 458 TCC>TCT Ser>Ser p.S458S
20 13299 A>G ND5 321 CAA>CAG Gln>Gln p.Q321Q
21 12372 G>A ND5 12 CTG>CTA Tyr>Tyr p.T12T
22 12373 A>G ND5 13 ACT>GCT Thr>Ala p.T13A
23 12406 G>A ND5 24 GTT>ATT Val>Ile p.V24I
24 12486 C>T ND5 50 CCC>CCT Pro>Pro p.P50P
25 12498 C>T ND5 54 TTC>TTT Phe>Phe p.F54F
26 12561 G>A ND5 75 CAG>CAA Gln>Gln p.Q75Q
27 13731 A>G ND5 465 GGA>GGG Gly>Gly p.G465G
28 13806 C>T ND5 490 GCC>GCT Ala>Ala p.A490A
29 14058 C>T ND5 574 TCC>TCT Ser>Ser p.S574S
         Abbreviations: A – Adenine; T – Thymine; G- Guanine; C- Cytosine; ND1 represents NADH dehydrogenase subunit 1, ND2
         represents NADH dehydrogenase subunit 2;ND3- NADH dehydrogenase subunit 3; ND4-NADH dehydrogenase subunit 4;
         ND5- NADH dehydrogenase subunit 5.
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DISCUSSION
In this study we analyzed mitochondrial complex 1 gene in 20
keratoconus patients (negative for VSX1 mutations [13]) and
20 unrelated healthy controls. The cornea, being an avascular
structure and the first in line of ultraviolet (UV) radiation, is
very susceptible to UV induced oxidative damage. Previous
studies [10,11] suggested the role of oxidative stress in corneal
disorders and congenital glaucoma [12]. Since the complex 1
NADH group of genes are most frequently associated with
increased ROS production and oxidative stress [12,24], in this
pilot study we analyzed mitochondrial complex I gene for
sequence variations. Most of the mutations were found in
ND5 (n=28) followed by ND4 (15) and then ND2 (13). The
frequent variations in ND5 are in accordance with previous
reports that mutations in ND5 gene of complex 1 play an
important role in mitochondrial diseases [25].
In this study we report two novel frame shift mutations.
Patient (KC 2) harbored a two base deletion (CA) which
caused a frameshift and introduced a stop codon at position
287 in protein (normal ND2 protein is 347 amino acids long).
The truncated protein cannot substitute the wild type ND2
protein  as  frameshift  altered  the  reading  frame  of  ND2.
Sequence variations in this gene are associated with severaldiseases  e.g.,  Leigh  syndrome,  breast  cancer,  myocardial
infarction,  Parkinson  disease,  and  primary  congenital
glaucoma (PCG) [12,26-29].
Patient (KC 16) harbored a single base deletion which
resulted in a frame shift mutation after codon 172 (Gly>Ala)
and introduced a stop codon at position 174 in protein and
produced a truncated protein of 173 amino acids (wild type
ND4 protein is 459 amino acids long).
Studies have documented that G10398A is associated
with  elevated  ROS  production  due  to  altered  complex  1
function  [29-32].  Role  of  this  allele  G10398A  has  been
implicated in diseases like congenital glaucoma, Parkinson,
Type-2  diabetes,  and  in  pre-term  births  [12,29-33].  The
G10398A variation though associated with high ROS levels
was  present  significantly  higher  in  cases  as  compared  to
controls however this is present in 43% Indian population. The
4216T>C variation considered as secondary or intermediate
LHON-Leber’s  Hereditary  optic  neuropathy  mutation  was
also present in 3 patients. However these patients had no
features of LHON.
Evolutionary  insight  of  Mt  complex  I  sequence
variations: The genetic diversity in India is very complex.
Several  mutations  from  even  control  regions  have  been
classified into the associative agent for various diseases [34].
The degree of haplotype sharing between populations is to
investigate the combined frequency of the shared haplotypes
in two population groups. Thus, among the northern and the
southern population groups the combined frequency of the
TABLE 5. MITOCHONDRIAL DNA SEQUENCE VARIATIONS (NON-SYNONYMOUS) DETECTED IN KC PATIENTS.
Sample
number
Nucleotide
substitution
Amino acid change Change in
protein
SIFT
score
SIFT
prediction
Polyphen score
2 4216T>C Tyr>His p.Y304H 0.82 Tolerant 0.008
3 4917 A>G Asn>Asp p.N150D 0.14 Tolerant 0.006
4 5046 G>A Val>Ile p.V193I 0.61 Tolerant 0.000
5 4833 A>G Thr>Ala p.T122A 0.10 Tolerant 0.135
6 4682 C>A Leu>Ile p.L71I 0.01 Pathogenic 0.001
7 4696 T>C Phe>Ser p.F76S 0.14 Tolerant 0.000
8 5300T>T p.Ile277His fs X11 p.I287X      
9 5460 G>A Ala>Thr p.A331T 0.37 Tolerant 0.000
10 10084T>C Ile>Thr p.I9T 0.49 Tolerant 0.000
11 10398 G-A Ala>Thr p. A 114 T 1.00 Tolerant 0.000
12 11273G>C p.gly172AlafsX2 p.L174X      
13 11969G>A Ala>Thr p.A404T 0.13 Tolerant 0.000
14 12361A>G Thr>Ala p.T9A 0.00 Pathogenic Not available
15 12426C>A Asn>Lys p.N30L 0.21 Tolerant 0.899
16 12850G>A Val >Ile p. I172V 1.00 Tolerant 0.422
17 13637A>G Glu>Arg p.Q434R 0.41 Tolerant 0.008
18 13768T>C Phe>Ile p.F478I 0.17 Tolerant 0.005
Figure  1.  Mt  DNA  sequence
chromatogram  of  ND4  gene.  A:  The
reference sequence derived from control
is  shown.  B:  Sequence  derived  from
keratoconus  patient  K16  shows  a
deletion of G at11273, which cause a
codon  change  GGC>GCT  and
p.gly172AlafsX2 (p.L174X) mutation.
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lower than that which we observed in the case of random
groups. This is not surprising because West Eurasian-specific
mtDNA haplogroups are rather frequent in northwest India
[35]. Because the Indo-European and the Dravidic speakers
of India are largely concentrated to the northern and southern
parts of the subcontinent, respectively, the differences arising
from  geographic  division  of  the  Indian  populations  also
Figure  2.  Mt  DNA  sequence
chromatogram of ND2 CA Deletion. A:
The  reference  sequence  derived  from
control is shown. B: Sequence derived
from keratoconus patient K2 shows two
base deletion CA at 5300, which causes
a  codon  change  ATC>ATT  and
p.Ile277His fsX11(p.I287X) mutation.
Figure  3.  PCA  plot  of  keratoconus
patients with Indian population.
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correspond to different linguistic groupings [36]. In this study,
we found that all the mutations were apparently North-Indian
specific  with  some  novel  mutations.  The  sequencing  of
Complex 1 revealed 84 mutations, of which 14, including 2
frame shift mutations and 4 non-synonymous mutations, were
novel and exclusively observed in KC patients. Interestingly,
most of the patients and their maternal relatives were clustered
under  the  haplogroups  (T,  C4a2a,  R2’TJ,  M21’Q1a,M12’G2a2a, M8’CZ, M7a2a, U5b1, U1a3) which are present
as negligible frequency in normal Indian population, whereas
only few patients were found to be a part of the haplogroups
whose origin is contentious i.e., U7 (Indo-European), R2 and
R31. We have found three patients who fall under Indian
haplogroups (M4, M4’63, R31a1) but they also carry the same
sets of novel synonymous and non-synonymous mutations
i.e., 4769, 4985, 5580, and 12850 (Figure 4). We have found
some novel mutations in addition to each individual’s lineages
and they are different from each other. This finding suggests
the positive/causative role of different combinations of the
mitochondrial coding mutations in this disease, as the normal
population, completely lack these mutations.
The  patients  harbored  some  novel  mutations  at  the
different sites in mitochondria i.e., 4769, 4985, 5580, and
12850. These variants have never been reported in any of the
population studies whereas they were present in every patient.
Nevertheless, it is impossible from the evolutionary point of
view that  these  sets  of  mutations  in  the  individuals  from
different haplogroup. By keeping in mind about mutation rates
in the coding region and its natural selection [37], we propose
that these variants could theoretically influence the patient’s
phenotype. However, the variants present in coding regions
of  mitochondrial  gene  are  not  conserved  in  course  of
evolution. The patients were apparently homoplasmic (only
one type of mtDNA was present). To determine whether the
maternal inherited gene pool of keratoconus patients is truly
closer to any major populations in India, we have constructed
the haplogroup frequency based PCA plot for mtDNA (Figure
3). Indeed, this analysis shows ambiguously that the three
Indian  populations  clusters  tightly  among  themselves  viz.
North, North West and West populations and two populations
are to be found in a loose cluster viz South Indian and East
Indian,  whereas  the  keratoconus  population  matches  with
none of them in the mtDNA PCA plots. However the genetic
data indicates that the keratoconus patients comprise several
different  haplotypes,  if  they  are  compared  to  normal
populations around them. Most of the patients are in the clades
which are nonspecific to Indian lineages. This information
suggests that keratoconus patients are among those who are
Figure 4. Network tree of the keratoconus patients and their comparison with other normal population.
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have acquired mutations which are not filtered by purifying
selection. Our results explain that the patients are genetically
unrelated to each other due to the present maternal lineages
which were diversified in the history of evolution. This fact
suggests that the polymorphisms which are playing pivotal
roles in causing the disease are recently accumulated in the
mitochondrial coding regions of an individual patient. We
have found that mutations specifically found in KC patients
can affect transcription, translation or have synergistic effect
with other variants in causing the disease. It has been reported
many times about synergistic effect of different mutations in
mitochondria  that  can  cause  many  severe  diseases  [38].
Nevertheless, it is impossible from the evolutionary point of
view these sets of mutations to occur in the normal individual
from  different  haplogroups.  By  keeping  in  mind  about
mutation rates in the coding region and its natural selection,
we propose that these variants could theoretically influence
the patient’s disease. Non-synonymous mutations and frame
shift mutations adversely affect C1 synergetics resulting in
increase ROS production and mitochondrial dysfunction. KC
corneas are unable to process ROS due to depleted or low ATP
levels and increased ROS production and thereby undergo
oxidative damage. These corneas have increased levels of
malondialdehyde (MDA), which can results in altered protein
function leading to cascade of events, including apoptosis that
can damage the corneal tissues.
Thus  this  pilot  study  highlights  the  role  of  sequence
variation in mitochondrial complex I gene in keratoconus
patients. Such cases with elevated free radicals levels and
oxidative  damage  to  cornea  may  benefit  immensely  by
antioxidant therapy.
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